To see the safety and efficacy of Mulmina D in improving the overall general health, physical, psychological and quality of life, in geriatric volunteers.

Phase 3

Completed

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2021/10/037286
• Lead Sponsor: Jagdale industries pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-12-31
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

i. Individual is at least 55 years old but not older than 85 years

ii. Diabetic subjects who are non-insulin dependent (NIDD)

iii. Individual is not simultaneously enrolled in another program promoting either well-being or physical activity

iv. Individual is with mild to moderate hypertensive, diabetic or other co-morbidities that are of no immediate life threatening to the volunteer

v. Subjects willing to refrain from using any external supplements like Vitamins and Minerals during the trial period.

Exclusion Criteria

i. Pregnancy or breast feeding.

ii. Evidence of significant uncontrolled co-morbid diseases which in the investigators opinion would jeopardize patient participation.

iii. History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ.

iv. Any neurological congenital or acquired vascular or systemic disorder which could affect any of the efficacy assessments.

v. Participation in the current or previous treatment with any approved or investigational health supplements during the past 1 month.

Study & Design

• Study Type: Interventional
• Study Design: Not specified